PAPER
Synthesis of a-Difluorovinyl-Substituted b-Enaminoesters and b-Ketoesters
1473
MS (EI, 70 eV): m/z (%) = 374 (1) [M + H+], 328 (3), 282 (59), 254
(50), 232 (3), 218 (2), 206 (11), 186 (36), 158 (5), 130 (8), 118 (9),
115 (6), 92 (9), 91 (100), 77 (4), 65 (14), 41 (4).
HRMS (EI): m/z [M+ – OEt] calcd for C19H16F2NO2: 328.115;
found: 328.113.
Ethyl 3-Amino-2-(1-benzyloxy-2,2-difluoro-1-vinyl)-2,4-hexa-
dienoate (3g)
IR (KBr): 3446, 3313, 2980, 1755, 1665, 1650, 1597, 1505, 1455,
1367, 1252, 1136, 1032, 962, 915, 739, 698 cm–1.
1H NMR (300 MHz, CDCl3): d = 1.23 (t, J = 7.2Hz, 3 H), 1.81 (d,
J = 5.7 Hz, 3 H), 4.14 (q, J = 7.2 Hz, 2 H), 4.70 (s, 2 H), 6.17–6.21
(m, 2 H), 7.26–7.33 (m, 5 H).
19F NMR (282 MHz, CDCl3): d = –101.3 (d, J = 62.9 Hz, 1 F),
–110.6 (d, J = 62.9 Hz, 1 F).
MS (EI, 70 eV): m/z (%) = 323 (1) [M+], 294 (1), 278 (1), 248 (1),
232 (21), 204 (14), 186 (2), 182 (11), 173 (2), 156 (10), 136 (7), 118
(2), 92 (8), 91 (100), 68 (12), 65 (7).
Ethyl 4,4-Difluoro-3-benzyloxy-2-(aminophenylmethene)-3-
butenoate (3d)
IR (KBr): 3463, 3418, 3306, 3032, 2980, 1754, 1663, 1598, 1575,
1523, 1488, 1444, 1366, 1263, 1141, 1024, 965, 774, 739, 699, 541
cm–1.
1H NMR (300 MHz, CDCl3): d = 1.24 (t, J = 7.1 Hz, 3 H), 4.18 (q,
J = 7.1 Hz, 2 H), 4.71 (s, 2 H), 5.12 (br s, 1 H), 7.24–7.44 (m, 10 H),
9.00 (br s, 1 H).
19F NMR (282 MHz, CDCl3): d = –100.9 (d, J = 65.4 Hz, 1 F),
–109.4 (d, J = 65.4 Hz, 1 F).
Anal. Calcd for C17H19F2NO3: C, 63.15; H, 5.92; N, 4.33. Found: C,
63.43; H, 6.05; N, 4.28.
Hydrolysis of Enaminoesters 3; General Procedure
MS (EI, 70 eV): m/z (%) = 314 (1) [M+ – OEt], 269 (6), 268 (40),
240 (28), 222 (5), 218 (7), 192 (14), 190 (8), 145 (2), 129 (6), 117
(3), 104 (41), 92 (11), 91 (100), 77 (9), 65 (16), 43 (21).
To a solution of enaminoester 3 (1 mmol) in either EtOH or EtOAc
(25 mL) was added HCl (2 N, 8 mL). The mixture was stirred at r.t.
for the time specified in Table 2 until TLC analysis showed com-
plete conversion of the enaminoester, then H2O (10 mL) was added
and the mixture was extracted with EtOAc (3 × 20 mL). The com-
bined organic extracts were washed with brine (30 mL), dried
(Na2SO4) and evaporated to dryness. The residue was purified by
column chromatography (n-hexane–EtOAc, 40:1) to give the a-di-
fluorovinyl substituted b-ketoesters 5 as colorless oils.
Anal. Calcd for C20H19F2NO3: C, 66.84; H, 5.33; N, 3.90. Found: C,
66.77; H, 5.43; N, 4.20.
Ethyl 4,4-Difluoro-3-benzyloxy-2-[amino(3-methylphen-
yl)methene]-3-butenoate (3e)
IR (KBr): 3462, 3419, 3305, 2981, 2931, 1755, 1663, 1599, 1583,
1519, 1482, 1455, 1367, 1266, 1215, 1133, 1102, 1028, 1001, 965,
913, 792, 736, 698 cm–1.
1H NMR (300 MHz, CDCl3): d = 1.23 (t, J = 7.1 Hz, 3 H), 2.33 (s,
3 H), 4.18 (q, J = 7.1 Hz, 2 H), 4.70 (s, 2 H), 5.08 (br s, 1 H), 7.20–
7.34 (m, 9 H), 8.99 (br s, 1 H).
19F NMR (282 MHz, CDCl3): d = –101.5 (d, J = 64.6 Hz, 1 F),
–110.1 (d, J = 64.6 Hz, 1 F).
Ethyl 3-Hydroxy-2-(1-benzyloxy-2,2-difluoro-1-vinyl)-2-
butenoate (5a)
IR (KBr): 2984, 2937, 1755, 1644, 1608, 1455, 1404, 1381, 1338,
1271, 1235, 1133, 1063, 1014, 941, 878, 740, 698 cm–1.
1H NMR (300 MHz, CDCl3): d = 1.29 (t, J = 7.1 Hz, 3 H), 1.97 (s,
3 H), 4.25 (q, J = 7.1 Hz, 2 H), 4.72 (s, 2 H), 7.27–7.37 (m, 5 H),
13.40 (s, 1 H).
MS (EI, 70 eV): m/z (%) = 328 (1) [M+ – OEt], 282 (50), 254 (34),
236 (11), 232 (14), 214 (1), 206 (15), 204 (7), 186 (5), 159 (2), 143
(7), 130 (4), 118 (40), 103 (2), 92 (8), 91 (100), 77 (4), 65 (15), 51
(2), 41 (1).
19F NMR (282 MHz, CDCl3): d = –100.0 (d, J = 62.0 Hz, 1 F),
–109.0 (d, J = 62.0 Hz, 1 F).
MS (EI, 70 eV): m/z (%) = 207 (15) [M+ – Bn], 190 (1), 179 (5), 157
(2), 129 (1), 111 (1), 92 (11), 91 (100), 65 (11), 43 (22).
Anal. Calcd for C21H21F2NO3: C, 67.55; H, 5.67; N, 3.75. Found: C,
67.46; H, 5.79; N, 3.57.
Anal. Calcd for C15H16F2O4: C, 60.40; H, 5.41. Found: C, 60.36; H,
5.50.
Ethyl 4,4-Difluoro-3-benzyloxy-2-[amino(2,4-dichlorophen-
yl)methene]-3-butenoate (3f)
IR (KBr): 3459, 3412, 3304, 2981, 2934, 1755, 1666, 1602, 1556,
1527, 1474, 1370, 1267, 1246, 1144, 1102, 1053, 1026, 966, 824,
796, 738, 698 cm–1.
1H NMR (300 MHz, CDCl3): d = 1.23 (t, J = 7.2 Hz, 3 H), 4.18 (q,
J = 7.2 Hz, 2 H), 4.68 (s, 2 H), 5.19 (br s, 1 H), 7.16–7.43 (m, 3 H),
8.96 (br s, 1 H).
19F NMR (282 MHz, CDCl3): d = –100.6 (br s, 1 F), –108.4 (br s,
1 F).
13C NMR (75.4 MHz, CDCl3): d = 169.1 (dd, 4JC–F = 2.9, 1.5 Hz),
160.6 (dd, 4JC–F = 4.2, 1.9 Hz), 154.2 (dd, 1JC–F = 291.1, 277.2 Hz),
112.8 (dd, 2JC–F = 41.0, 20.2 Hz), 87.9 (t, 3JC–F = 3.8 Hz), 65.5, 59.8,
14.2.
Ethyl 3-Hydroxy-2-(1-benzyloxy-2,2-difluoro-1-vinyl)-2-pen-
tenoate (5b)
IR (KBr): 3034, 2983, 2942, 2881, 1756, 1644, 1603, 1466, 1455,
1403, 1374, 1345, 1274, 1230, 1133, 1093, 1039, 739, 698 cm–1.
1H NMR (300 MHz, CDCl3): d = 1.05 (t, J = 7.2 Hz, 3 H), 1.18 (t,
J = 7.2 Hz, 3 H), 2.24 (q, J = 7.2 Hz, 2 H), 4.15 (q, J = 7.2 Hz, 2 H),
4.62 (s, 2 H), 7.21–7.28 (m, 5 H), 13.41 (s, 1 H).
19F NMR (282 MHz, CDCl3): d = –100.2 (d, J = 60.1 Hz, 1 F),
–109.1 (d, J = 60.1 Hz, 1 F).
MS (EI, 70 eV): m/z (%) = 221 (15) [M+ – Bn], 193 (6), 175 (2), 146
(1), 92 (7), 91 (100), 77 (1), 69 (1), 65 (7), 57 (13).
Anal. Calcd for C16H18F2O4: C, 61.53; H, 5.81. Found: C, 61.92; H,
5.78.
MS (EI, 70 eV): m/z (%) = 382 (1) [M+ – OEt], 338 (25), 336 (38),
310 (23), 308 (35), 288 (4), 286 (6), 262 (7), 260 (13), 197 (3), 185
(1), 174 (12), 172 (18), 92 (7), 91 (100), 65 (8).
HRMS (EI): m/z [M+] calcd for C20H1735Cl2F2NO3: 427.055; found:
427.055.
Ethyl 4-Phenyl-3-hydroxy-2-(1-benzyloxy-2,2-difluoro-1-vi-
nyl)-2-butenoate (5c)
IR (KBr): 3032, 2983, 2933, 1755, 1642, 1596, 1570, 1496, 1454,
1401, 1377, 1343, 1273, 1231, 1131, 1041, 944, 862, 739, 702 cm–1.
1H NMR (300 MHz, CDCl3): d = 1.24 (t, J = 7.2 Hz, 3 H), 3.65 (d,
J = 6.9 Hz, 2 H), 4.20 (q, J = 7.2 Hz, 2 H), 4.67 (s, 2 H), 7.23–7.35
(m, 10 H), 13.49 (s, 1 H).
Anal. Calcd for C20H17Cl2F2NO3: C, 56.09; H, 4.00; N, 3.27. Found:
C, 56.57; H, 4.09; N, 2.99.
Synthesis 2006, No. 9, 1470–1474 © Thieme Stuttgart · New York